Microglial degeneration in the aging brain--bad news for neurons?

Wolfgang J Streit1, Kelly R Miller, Kryslaine O Lopes

  • 1Department of Neuroscience, University of Florida, Gainesville, FL 32610, USA. streit@mbi.ufl.edu

Insights

Microglial cells, crucial for brain health, may decline with age and disease, contributing to neurodegeneration. This review explores microglial activation, senescence, degeneration, and their impact on aging brains.

Area of Science:

  • Neuroscience
  • Immunology
  • Cell Biology

Background:

  • Microglial cells are traditionally viewed as beneficial immune sentinels in the central nervous system (CNS).
  • They provide neuroprotection and support neuronal function, especially following injury.
  • Recent findings highlight degenerating microglial cells in aging and neurodegenerative diseases.

Purpose of the Study:

  • To review microglial activation, senescence, and degeneration.
  • To explore the role of oxidative stress in microglial degeneration.
  • To discuss microglial involvement in amyloid clearance and its compromise during aging.

Main Methods:

  • Literature review and synthesis of existing research on microglial function.
  • Comparative analysis of microglial activation versus senescence and degeneration.
  • Discussion of proposed mechanisms, including oxidative stress and amyloid degradation.

Main Results:

  • Microglial cells exhibit distinct characteristics when activated, senescent, or degenerating.
  • Oxidative stress is a potential contributor to microglial degeneration.
  • Impaired amyloid clearance by aging microglia may compromise neuroprotection.

Conclusions:

  • Loss of microglial neuroprotective functions may contribute to age-related neurodegeneration.
  • Understanding microglial dynamics is crucial for addressing neurodegenerative diseases.
  • Targeting microglial health could offer therapeutic strategies for aging brains.

Related Concept Videos

Alzheimer Disease ll: Pathophysiology01:23

Alzheimer Disease ll: Pathophysiology

Alzheimer disease involves structural changes in the brain that begin long before symptoms appear. The most distinctive features are extracellular neuritic plaques and intracellular neurofibrillary tangles.Neuritic plaques form in the cerebral cortex and around blood vessels. These plaques contain a dense core of beta-amyloid (Aβ)—a toxic protein fragment that clumps outside neurons. The core is surrounded by damaged neuronal extensions, as well as reactive astrocytes and microglia. Abnormal...
Neurogenesis and Regeneration of Nervous Tissue01:15

Neurogenesis and Regeneration of Nervous Tissue

In the CNS, neurogenesis, the birth of new neurons from stem cells, is limited to the hippocampus in adults. In other regions of the brain and spinal cord, neurogenesis is almost non-existent due to inhibitory influences from neuroglia, especially oligodendrocytes, and the absence of growth-stimulating cues. The myelin produced by oligodendrocytes in the CNS inhibits neuronal regeneration. Furthermore, astrocytes proliferate rapidly after neuronal damage, forming scar tissue that physically...
Parkinson Disease ll: Pathophysiology01:24

Parkinson Disease ll: Pathophysiology

Parkinson disease (PD) is a progressive neurodegenerative disorder primarily affecting movement, with additional non-motor features. Its pathophysiology involves complex interactions among genetic susceptibility, environmental exposures, and cellular dysfunction, including dopaminergic neuron loss, protein aggregation, and mitochondrial impairment.Selective NeurodegenerationA key feature is the degeneration of dopaminergic neurons in the substantia nigra pars compacta, leading to reduced...
Neural Regulation01:37

Neural Regulation

Digestion begins with a cephalic phase that prepares the digestive system to receive food. When our brain processes visual or olfactory information about food, it triggers impulses in the cranial nerves innervating the salivary glands and stomach to prepare for food.
Alzheimer Disease l: Introduction01:29

Alzheimer Disease l: Introduction

Alzheimer disease is a chronic, progressive, and irreversible neurodegenerative disorder and the most common cause of dementia in older adults. It leads to gradual neuronal loss, causing cognitive decline, behavioral changes, and loss of functional independence.Risk Factors and EtiologyThe disease is multifactorial. Age is the strongest risk factor, with prevalence doubling every 5 years after age 65. Genetic factors include mutations in genes such as APP, PSEN1, and PSEN2, which are associated...